Haemodialysis monocytopenia: Differential sequestration kinetics of CD14+CD16+ and CD14++ blood monocyte subsets

Clinical and Experimental Immunology

Volumn 123, Issue 1, 2001, Pages 49-55

  Nockher, W A ^a   Wiemer, J ^b   Scherberich, J E ^b  

^a KLINIKUM BOGENHAUSEN   (Germany)

^b Hospital Mu nchen Harlaching   (Germany)

Author keywords

CD14+CD16+; Haemodialysis; Monocytes; Monocytopenia; Sequestration; Subset

Indexed keywords

CD11 ANTIGEN; CELL SURFACE RECEPTOR;

ARTICLE; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPENIA; DIALYSIS MEMBRANE; GENE EXPRESSION; HEMODIALYSIS; HUMAN; KINETICS; LEUKOCYTE; LEUKOCYTE COUNT; MONOCYTE; MONOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0035143411     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01436.x     Document Type: Article

References (40)

1. Profound neutropenia during the early phase of hemodialysis
2. Hemodialysis leukopenia: Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes
3. A major role for CD62P/CD15s interaction in leukocyte margination during hemodialysis
4. Effect of hemodialysis on leukocyte adhesion receptor expression
5. Dialysis neutropenia. The role of the cytoskeleton
6. Clinical implications of hemodialysis membrane biocompatibility
7. Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high-flux biocompatible membrane
8. Differentially regulated cell surface expression of leukocyte adhesion receptors on neutrophils
9. The changes of Mac-1 and L-selectin expression on granulocytes and soluble L-selectin level during hemodialysis
10. Identification and characterization of a novel monocyte subpopulation in human peripheral blood
11. + subpopulation
12. The novel subset of CD14+/CD16+ blood monocytes exhibit features of tissue macrophages
13. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients
14. + monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis
15. + monocytes from leukapheresis collections for peripheral blood progenitors
16. CD14lowCD16high: A cytokine-producing monocyte subset which expands during human immunodeficiency virus infection
17. + blood monocytes is expanded in sepsis patients
18. Generalized immune activation in pulmonary tuberculosis: Co-activation with HIV infection
19. Blood monocytes of untreated asthmatics exhibit some features of tissue macrophages
20. CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy
21. Differential cytokine expression in human blood monocyte subpopulations: A polymerase chain reaction analysis
22. + monocyte subset
23. Long-term dialysis and cellular immunity: A critical survey
24. Immunological considerations of the uremic and dialyzed patient
25. Altered monocyte function in uremia
26. Enhanced scavenger receptor expression in monocyte-macrophages in dialysis patients
27. Dialysis-induced serum factors inhibit adherence of monocytes and granulocytes to adult human endothelial cells
28. Monocyte production of transforming growth factor beta in long-term hemodialysis: Modulation by hemodialysis membranes
29. Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell level
30. Interleukin-1 receptor antagonist synthesis by peripheral blood mononuclear cells in hemodialysis patients
31. Cooperation between CR1 (CD35) and CR3 (CD11b/CD18) in the binding of complement-opsonized particles
32. Pulmonary bed sequestration of neutrophils during hemodialysis
33. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis
34. PECAM-1 is required for transendothelial migration of leukocytes
35. Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18)
36. + monocytes in the marginal pool
37. Selective mobilization of CD14+CD16+ monocytes by exercise
38. + monocytes by glucocorticoid therapy
39. Blood monocyte phenotypes and soluble endotoxin receptor CD14 in systemic inflammatory diseases and in patients with chronic renal failure
40. Alterations in the number of circulating leucocytes, phenotype of monocyte and cytokine production in patients undergoing cardiothoracic surgery